Bio Protocol Launches OpenLabs on July 3, Introduces USDC Yield-Based Funding for AI-Science Collaboration

BIO0.38%
MORPHO-4.56%
AAVE0.86%

According to BlockBeats, Bio Protocol launched OpenLabs on July 3, a coordination layer for human-AI collaboration in scientific research. The platform features five interconnected layers: posts and discovery, projects, AI agent collaboration, Web3 incentives, and a bounty system.

OpenLabs employs a USDC yield-based financing mechanism where users deposit stablecoins to support projects. Funds are deployed to audited yield vaults on Morpho and Aave, with generated yields flowing to projects for computation, queries, and simulations while protecting depositor principal. Once projects advance to requiring real capital, they can launch tokens via Bio's launchpad or pursue traditional biotech financing routes.

Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments